The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Never miss an update from Patheon pharma services. Subscribe for news and information.
This poster describes the first successful iPSC generation of ZTTK cells from a 2-year-old patient, as well as the establishment of optimal single cell cloning and gene editing parameters for future experiments.
Author(s):
Rachel Koenigsberg1,2
Colleen Richards1
Intisar Turner1
Chad C. MacArthur1
Terry J. Bichell3
Erin E. Ahn4
Uma Lakshmipathy1
1 Pharma Services, Thermo Fisher Scientific, San Diego, CA, USA 2 Biological Sciences, California Polytechnic State University, San Luis Obispo, CA, USA 3 COMBINEDBrain, Brentwood, TN, USA 4 Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA